A glycan gate controls opening of the SARS-CoV-2 spike protein

Terra Sztain,Surl-Hee Ahn,Anthony T. Bogetti,Lorenzo Casalino,Jory A. Goldsmith,Evan Seitz,Ryan S. McCool,Fiona L. Kearns,Francisco Acosta-Reyes,Suvrajit Maji,Ghoncheh Mashayekhi,J. Andrew McCammon,Abbas Ourmazd,Joachim Frank,Jason S. McLellan,Lillian T. Chong,Rommie E. Amaro
DOI: https://doi.org/10.1038/s41557-021-00758-3
IF: 24.274
2021-08-19
Nature Chemistry
Abstract:SARS-CoV-2 infection is controlled by the opening of the spike protein receptor binding domain (RBD), which transitions from a glycan-shielded 'down' to an exposed 'up' state to bind the human angiotensin-converting enzyme 2 receptor and infect cells. While snapshots of the 'up' and 'down' states have been obtained by cryo-electron microscopy and cryo-electron tomagraphy, details of the RBD-opening transition evade experimental characterization. Here over 130 µs of weighted ensemble simulations of the fully glycosylated spike ectodomain allow us to characterize more than 300 continuous, kinetically unbiased RBD-opening pathways. Together with ManifoldEM analysis of cryo-electron microscopy data and biolayer interferometry experiments, we reveal a gating role for the N-glycan at position N343, which facilitates RBD opening. Residues D405, R408 and D427 also participate. The atomic-level characterization of the glycosylated spike activation mechanism provided herein represents a landmark study for ensemble pathway simulations and offers a foundation for understanding the fundamental mechanisms of SARS-CoV-2 viral entry and infection.
chemistry, multidisciplinary
What problem does this paper attempt to address?